Specifically, in patients affected by melanoma and metastatic leyomiosarcoma, PTEN loss was demonstrated to contribute to immunosuppressive cells infiltration in tumors, while avoiding lymphocytes accumulation (108, 109). This evidence concerns the gene PTEN and melanoma.